Home › Funds › TSP Capital Management Group, LLC › NVAX

TSP Capital Management Group, LLC position in NVAX

NOVAVAX INC · Health Care

TSP Capital Management Group, LLC reported holding 1,432,365 shares of NVAX (NOVAVAX INC) in its Q3 2026 13F filing — a position valued at US$15.5M, representing 3.90% of its reported portfolio and ranking #10 among its reported holdings. TSP Capital Management Group, LLC has disclosed NVAX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.43M sh
Reported value held$15.48M
Portfolio Weight3.90%
First reportedQ3 2023
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How TSP Capital Management Group, LLC's NVAX position evolved

TSP Capital Management Group, LLC first disclosed a stake in NVAX in Q3 2023 at 966,350 shares (US$7.0M). The position peaked in Q2 2024 at 1,377,125 shares, worth US$17.4M. Across 13 filings, TSP Capital Management Group, LLC increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 1,432,365 shares valued at US$15.5M — an increase of 13,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 966.35K $7.00M New
Q4 2023 1.11M $5.34M Add
Q1 2024 1.38M $6.58M Add
Q2 2024 1.38M $17.43M Hold
Q3 2024 1.35M $17.06M Reduce
Q4 2024 1.36M $10.92M Add
Q1 2025 1.35M $8.67M Hold
Q2 2025 1.40M $8.81M Add
Q3 2025 1.40M $12.13M Hold
Q4 2025 1.39M $9.33M Reduce
Q1 2026 1.39M $11.32M Hold
Q2 2026 1.42M $13.37M Add
Q3 2026 1.43M $15.48M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVAX and 13F data

NVAX (NOVAVAX INC) is a Health Care company. 26 other funds we track also report a position in NVAX — the largest reported positions include SHAH CAPITAL MANAGEMENT (US$131.6M), Sanofi (US$64.8M), Coatue Management (US$36.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVAX

All NVAX fund holders →

FAQ

How long has TSP Capital Management Group, LLC held NVAX?

TSP Capital Management Group, LLC has disclosed NVAX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is TSP Capital Management Group, LLC's current position in NVAX?

As of Q3 2026, TSP Capital Management Group, LLC holds 1.43M shares of NVAX (NOVAVAX INC), valued at $15.48M, representing 3.90% of its reported portfolio and ranking #10.

Has TSP Capital Management Group, LLC been buying or selling NVAX?

In the latest 13F filing (Q3 2026), TSP Capital Management Group, LLC increased its position in NVAX. The position peaked in Q2 2024 at 1.38M shares.

Which other funds hold NVAX?

Other major institutional holders of NVAX include SHAH CAPITAL MANAGEMENT, Sanofi, Coatue Management, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.